Segall Bryant & Hamill’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.44M Sell
19,346
-2,064
-10% -$154K 0.02% 471
2025
Q1
$1.36M Buy
+21,410
New +$1.36M 0.02% 474
2024
Q4
Sell
-62,621
Closed -$5.03M 602
2024
Q3
$5.03M Buy
62,621
+407
+0.7% +$32.7K 0.07% 330
2024
Q2
$5.15M Buy
+62,214
New +$5.15M 0.09% 287
2021
Q2
Sell
-65,691
Closed -$7.3M 793
2021
Q1
$7.3M Sell
65,691
-58,689
-47% -$6.52M 0.07% 268
2020
Q4
$14.8M Sell
124,380
-8,278
-6% -$983K 0.16% 153
2020
Q3
$11.6M Buy
132,658
+88,719
+202% +$7.74M 0.16% 146
2020
Q2
$3.93M Buy
43,939
+36,423
+485% +$3.26M 0.07% 250
2020
Q1
$749K Buy
+7,516
New +$749K 0.02% 499
2018
Q3
Sell
-38,368
Closed -$3.44M 856
2018
Q2
$3.44M Sell
38,368
-28,067
-42% -$2.52M 0.05% 350
2018
Q1
$4.86M Sell
66,435
-119,679
-64% -$8.76M 0.11% 201
2017
Q4
$10.8M Sell
186,114
-12,576
-6% -$730K 0.24% 111
2017
Q3
$8.92M Sell
198,690
-3,730
-2% -$167K 0.21% 119
2017
Q2
$7.99M Buy
202,420
+63,748
+46% +$2.52M 0.19% 124
2017
Q1
$5.63M Buy
138,672
+19,908
+17% +$808K 0.14% 163
2016
Q4
$4.77M Buy
118,764
+1,447
+1% +$58.2K 0.12% 182
2016
Q3
$4.25M Buy
117,317
+49,865
+74% +$1.81M 0.11% 198
2016
Q2
$1.96M Buy
67,452
+16,645
+33% +$482K 0.05% 292
2016
Q1
$1.78M Buy
+50,807
New +$1.78M 0.04% 307
2015
Q3
Sell
-87,108
Closed -$3.6M 554
2015
Q2
$3.6M Buy
87,108
+1,015
+1% +$42K 0.08% 259
2015
Q1
$3.87M Sell
86,093
-175
-0.2% -$7.86K 0.09% 247
2014
Q4
$3.23M Buy
86,268
+17,865
+26% +$668K 0.07% 270
2014
Q3
$2.39M Buy
68,403
+54,510
+392% +$1.9M 0.06% 289
2014
Q2
$490K Sell
13,893
-28,011
-67% -$988K 0.01% 439
2014
Q1
$1.37M Sell
41,904
-12,038
-22% -$392K 0.03% 304
2013
Q4
$2.27M Sell
53,942
-3,609
-6% -$152K 0.05% 259
2013
Q3
$2.3M Buy
57,551
+759
+1% +$30.3K 0.06% 257
2013
Q2
$2.35M Buy
+56,792
New +$2.35M 0.06% 249